Iopamiro injection is the second-generation non-ionic iodinated Contrast Media launched in the global market. In 2015, Beilu firstly launched and listed iopamidol 370 Injection, one of the most widely used types of contrast medium in the Chinese market. 

Product name: Iopamidol Injectionnon

Generic name: Iopamidol Injection

Type: Injectable Contrast Media for CT/X-ray

Ingredients: Iopamidol

Specification:

(1) 50ml: 15 gl

(2) 100ml: 30 gl

(3) 50ml: 18.5 gl

(4) 100ml: 37 gl

Administration: Intravascular injection

Adverse reactions: The application of organic iodine compounds can cause adverse reactions, as well as allergic or drug-induced shock. See the details from the package insert

Shelf life: 36 months

Advantages of iopamidol 300 Injection

High enhancement value, which increased the contrast between the lesion and solid organs, improved the lesion detection.

Low viscosity

Low osmotic pressure

Low injection speed, which reduces vascular pressure and prevents contrast media extravasation (patient with poor tolerance, such as children, elderly, diabetes or tumor patients, are more suitable for high-concentration contrast media)

The low total dosage of Contrast media

Low radiation dose

Indications of Iopamidol Injection

Neuroradiology: Spinal nerve root angiography, Cisternography and ventriculography.

Angiography: Cerebral arteriography, Coronary angiography, Thoracic aorta and abdominal aorta angiography, Angiocardiography, Selectivevisceral arteriography, Peripheral arteriography and venography, Digital subtraction angiography of cerebral arteries, peripheral arteries and abdominal arteries.

Urinary system angiography: Venous urography, Enhanced scan in CT examination, Arthrography, Fistula angiography, Digital subtraction angiography.

Precautions please refer to the package insert.